- Abstract viewed - 1117 times
- PDF downloaded - 1682 times
Copyright
© Clujul Medical, 2019
Affiliations
Teodora Alexescu
UMF „Iuliu Haţieganu” Cluj-Napoca
Vasile Negrean
UMF „Iuliu Haţieganu” Cluj-Napoca
Nicolae Rednic
Spitalul Clinic CF Cluj-Napoca
Olga Orăşan
UMF „Iuliu Haţieganu” Cluj-Napoca
Monica Lencu
Spitalul Clinic CF Cluj-Napoca
Simina Ţărmure
UMF „Iuliu Haţieganu” Cluj-Napoca
How to Cite
METHODS OF ASSESSING LIVER MORPHOLOGY
Vol 84 No 4 (2011)
Section: Reviews
Pages: 481-485
Abstract
Due to the increasing incidence and prevalence of patients with chronic liver diseases, especially hepatitis B and / or hepatitis C virus infection, we need advanced medical instruments for measuring liver fibrosis and prognosis estimation, necessary to establish standardized indications for antiviral therapy and to monitor the response to therapy.
We will review the methods for assessing liver morphology: invasive methods (liver biopsy, currently considered the “gold standard” in the diagnosing and staging of chronic liver disease) and new noninvasive methods for assessment of the liver, such as: serum biomarkers, elastography, Fibrotest, Fibromax, Hepascore, APRI (AST / pallets ratio index), ASPRI (age-spleen-platelet index), ELF (the European Liver fibrosis panel), ARFI (Acoustic Radiation Force Impulse Imaging), S-index.